Therefore, future preclinical and clinical trials with the combined use of metformin or other mitochondrial respiration inhibitors with chemotherapy should be considered in AML mice and patients, especially those with MLL/AF9 mutation. Here, MLLT3 is linked to acute myeloid leukemia.